Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy

NCT04893655 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT04893655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04893655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Completed
Start date
September 14, 2021
Completion date
July 25, 2023
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

general anesthesia